Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Merrill, Joan
Item TypeName
Concept Drug Therapy, Combination
Concept Treatment Failure
Concept Treatment Outcome
Concept Withholding Treatment
Concept Molecular Targeted Therapy
Concept Estrogen Replacement Therapy
Academic Article Clinical trials for lupus--are we there yet?
Academic Article Rituximab: wanted dead or alive...
Academic Article Ending the 50-year drought of FDA drug approval for SLE.
Academic Article Herpes zoster vaccination in SLE: a pilot study of immunogenicity.
Academic Article Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study.
Academic Article Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials.
Academic Article Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.
Academic Article Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study.
Academic Article Why, why, why de-lupus (does so badly in clinical trials).
Academic Article Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial.
Academic Article Evaluating duration of response to treatment in systemic lupus erythematosus clinical trials.
Academic Article Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus.
Academic Article Immunologic findings precede rapid lupus flare after transient steroid therapy.
Academic Article Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach.
Academic Article SLE clinical trials: impact of missing data on estimating treatment effects.
Academic Article High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin.
Academic Article Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
Academic Article Emergence of targeted immune therapies for systemic lupus.
Academic Article Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus.
Academic Article New directions in the treatment of systemic lupus erythematosus.
Academic Article Connective tissue diseases: What does the death of Riquent hold for the future of SLE?
Academic Article Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
Academic Article Treatment of systemic lupus erythematosus: a 2012 update.
Academic Article Co-stimulatory molecules as targets for treatment of lupus.
Academic Article Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys.
Academic Article Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus.
Academic Article Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Academic Article A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-a) in patients with systemic lupus erythematosus (ROSE).
Academic Article Impact of standard of care treatments and disease variables on outcomes in systemic lupus erythematosus trials: analysis from the Lupus Foundation of America Collective Data Analysis Initiative.
Academic Article The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials.
Academic Article Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index.
Academic Article Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus: Results of a Twenty-Four-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase IIb Study.
Academic Article Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis.
Academic Article Author Correction: Immunologic findings precede rapid lupus flare after transient steroid therapy.
Academic Article Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study.
Academic Article Recurrent pregnancy loss with the antiphospholipid antibody: a systematic review of therapeutic trials.
Academic Article Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
Academic Article Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
Academic Article A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
Academic Article Disease-specific patient reported outcome tools for systemic lupus erythematosus.
Academic Article Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials.
Academic Article American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.
Academic Article Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial.
Academic Article Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosus.
Academic Article Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial.
Academic Article The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.
Academic Article Catastrophic antiphospholipid syndrome.
Academic Article Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
Academic Article Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis.
Academic Article A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.
Academic Article Novel evidence-based systemic lupus erythematosus responder index.
Academic Article The genetics of systemic lupus erythematosus and implications for targeted therapy.
Academic Article SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus.
Academic Article Safety profile and clinical activity of sifalimumab, a fully human anti-interferon a monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
Academic Article Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.
Academic Article Efficacy and safety of belimumab in patients with rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled, dose-ranging Study.
Academic Article Sifalimumab, an anti-interferon-a monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.
Academic Article Brief Report: Longitudinal Patterns of Response to Standard of Care Therapy for Systemic Lupus Erythematosus: Implications for Clinical Trial Design.
Academic Article Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.
Academic Article Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.
Academic Article Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.
Grant Polymorphisms of Antiphospholipid Protein Antigens
Grant SPORADIC MECHANISM OF THE ANTIPHOSPHOLIPID SYNDROME
Grant SPORADIC MECHANISM OF THE ANTIPHOSPHOLIPID SYNDROME
Academic Article Safety and clinical activity of atacicept in the long-term extension of the phase 2b ADDRESS II study in systemic lupus erythematosus.
Academic Article Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Search Criteria
  • Therapeutics